Trial intelligence / Profile preview

Dasatinib in relapsed or refractory PDGFRA-positive peripheral T-cell lymphoma

2013-005240-28Phase 2Completed

Sponsor

Sant'Orsola-Malpighi University Hospital

Start

Feb 2014

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1